- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
OliverWyman
OliverWyman is listed as a large business research supplier in the Scientist.com network, with 1 site in 1 country.
View OliverWyman on Scientist.com
Email me this page as a PDF
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Sites
1
Countries
1
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Large business
Commercial Consulting
- Portfolio Management Manage a portfolio of projects in early-stage drug discovery and provide factors that determine the success of the proposed portfolio.
HEOR
- Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
Market Access
- Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
- Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
- Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
- Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
- Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
- Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...
Medical Communications
- Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.
- Target Product Profile (TPP) A sponsor prepared document which summarizes the drug development program that is described in terms of the labelling concepts. This profile is a communication method used between the FDA and sponsor which can be used...
Regulatory Affairs
- Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
- Website
- www.oliverwyman.com
Where it operates
Sites by country, with the cities in each.
-
United Kingdom 1 site
Work with OliverWyman on Scientist.com
For prices, more details, or to contact OliverWyman, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.